NSABP FR-2: Phase II study of durvalumab following neoadjuvant chemoRT in stage II-IV rectal cancer.

George, TJ; Yothers, G; Lee, JJ; Jacobs, SA; Deutsch, M; Allegra, CJ; Wolmark, N

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (4):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索